Ignite Creation Date:
2024-05-06 @ 3:53 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02401347
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2015-03-24
Brief Title:
Phase II Trial of Talazoparib in BRCA12 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
Sponsor:
Organization:
Stanford University